By Josh White
Date: Friday 21 Mar 2025
(Sharecast News) - Angle announced on Friday the successful completion of assay development projects for AstraZeneca and Eisai, further expanding its portfolio of liquid biopsy solutions and strengthening its position as a partner to the pharmaceutical industry in oncology drug development.
By Josh White
Date: Friday 24 Jan 2025
(Sharecast News) - Liquid biopsy specialist Angle announced on Friday that its Parsortix system played a pivotal role in groundbreaking breast cancer research published in Nature Medicine by a team led by professor Nicola Aceto at ETH Zurich.
By Iain Gilbert
Date: Thursday 23 Jan 2025
(Sharecast News) - Analysts at Berenberg slashed their target price on liquid biopsy specialist Angle from 70.0p to 40.0p on Thursday but said the group was "repositioned for growth" in FY25.
Currency | UK Pounds |
Share Price | 10.50p |
Change Today | 0.50p |
% Change | 5.00 % |
52 Week High | 19.47p |
52 Week Low | 7.25p |
Volume | 3,598,449 |
Shares Issued | 322.64m |
Market Cap | £33.88m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
17:07 | 114,988 @ 10.50p |
16:28 | 51,843 @ 10.34p |
16:24 | 5,000 @ 10.36p |
12:38 | 8,000 @ 10.79p |
12:37 | 12,000 @ 10.79p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research